DNMT3B7 expression promotes tumor progression to a more aggressive phenotype in breast cancer cells.
Epigenetic changes, such as DNA methylation, have been shown to promote breast cancer progression. However, the mechanism by which cancer cells acquire and maintain abnormal DNA methylation is not well understood. We have previously identified an aberrant splice form of a DNA methyltransferase, DNMT...
Main Authors: | Patrick R Brambert, Daniel J Kelpsch, Rabia Hameed, Charmi V Desai, Gianfranco Calafiore, Lucy A Godley, Stacey L Raimondi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4301645?pdf=render |
Similar Items
-
Aberrant DNMT3B7 expression correlates to tissue type, stage, and survival across cancers.
by: Safia Siddiqui, et al.
Published: (2018-01-01) -
Independent functions of DNMT1 and USP7 at replication foci
by: Olya Yarychkivska, et al.
Published: (2018-02-01) -
Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome
by: Amanda M. Smith, et al.
Published: (2021-07-01) -
Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype
by: Janelle Cheung, et al.
Published: (2021-12-01) -
Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, and DNMT3B in Acute Myeloid Leukaemia
by: Kah Keng Wong, et al.
Published: (2019-05-01)